<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02802917</url>
  </required_header>
  <id_info>
    <org_study_id>18271</org_study_id>
    <nct_id>NCT02802917</nct_id>
  </id_info>
  <brief_title>To Evaluate Eye Installation-Tear Free</brief_title>
  <official_title>Evaluation of the Stinging Potential of Products in Human Eyes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study was to compare the human eye stinging potential of
      experimental formulas of sun care products [Sun Protection Factor (SPF) 50 Y49 091, SPF 50
      X15 158, SPF 50 X15 160 and SPF 50 X57 162 compared to an industry standard shampoo mixture.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective discomfort</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Score 0: No discomfort felt Score 1: Faint, barely perceptible discomfort Score 2: Mild, low intensity discomfort that does not prevent the subject from opening lids Score 3: Moderately intense discomfort that interferes with but does not prevent lid opening Score 4: Severe, very intense discomfort that makes voluntary lid opening difficult, requires force to pull lids apart, and results in the subject requesting washout of test article</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective lacrimation</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Score 0: No tearing or lid wetness above normal Score 1: Noticeable increase in moistness of lid edges - no frank tearing Score 2: Frank tearing - meager flow Score 3: Frank tearing - moderate flow Score 4: Frank tearing - copious flow</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective conjunctival inflammation</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Score 0: Inflammatory changes absent Score 1: Capillaries slightly more prominent than they were at time of baseline examination Score 2: Capillaries very prominent plus some diffuse conjunctival reddening Score 3: Vessels very prominent plus diffuse and confluent intense redness Score 4: Beefy redness and everted lids</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective cornea and iris inflammation</measure>
    <time_frame>up to 10 days</time_frame>
    <description>Score 0: No effect detected with use of slit lamp Score 1: Barely perceptible clouding or pitting of cornea or thickening of iris detected via slit lamp Score 2: Faint clouding or pitting of cornea and/or thickening of the iris Score 3: Moderate clouding or pitting of cornea and/or thickening of the iris Score 4: Intense clouding or pitting of cornea and/or thickening of the iris</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Sunscreening Agents</condition>
  <arm_group>
    <arm_group_label>SPF 50 Y49 091</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects were given the control article (standard shampoo mixture, X46 046) in one eye and one of the test articles in the other eye according to the randomization schedule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPF 50 X15 158</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects were given the control article (standard shampoo mixture, X46 046) in one eye and one of the test articles in the other eye according to the randomization schedule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPF 50 X15 160</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects were given the control article (standard shampoo mixture, X46 046) in one eye and one of the test articles in the other eye according to the randomization schedule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SPF 50 X57 162</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects were given the control article (standard shampoo mixture, X46 046) in one eye and one of the test articles in the other eye according to the randomization schedule.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPF 50 Y49 091 (BAY 987516)</intervention_name>
    <description>5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.</description>
    <arm_group_label>SPF 50 Y49 091</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPF 50 X15 158 (BAY 987516)</intervention_name>
    <description>5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.</description>
    <arm_group_label>SPF 50 X15 158</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPF 50 X15 160 (BAY 987516)</intervention_name>
    <description>5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.</description>
    <arm_group_label>SPF 50 X15 160</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPF 50 X57 162 (BAY 987516)</intervention_name>
    <description>5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.</description>
    <arm_group_label>SPF 50 X57 162</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>J &amp; J baby shampoo, X46 046 (control)</intervention_name>
    <description>5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.</description>
    <arm_group_label>SPF 50 Y49 091</arm_group_label>
    <arm_group_label>SPF 50 X15 158</arm_group_label>
    <arm_group_label>SPF 50 X15 160</arm_group_label>
    <arm_group_label>SPF 50 X57 162</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males or females, 18 to 60 years with no medical conditions of the eyes as
             determined by the subject's medical history and confirmed by an ophthalmologist

          -  Subjects not under any doctor's care for ocular or peri orbital diseases

          -  The subject will refrain from using contact lenses, any topical facial products, any
             eye drops, false eyelashes, make up, over the counter products, or cosmetics on their
             eyes, eyelids, eyelashes, or the periorbital areas of the face during the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <link>
    <url>http://pharma.bayer.com/en/innovation-partnering/clinical-trials/trial-finder/</url>
    <description>Click here to find results for studies related to Bayer Healthcare products.</description>
  </link>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2016</study_first_posted>
  <last_update_submitted>June 14, 2016</last_update_submitted>
  <last_update_submitted_qc>June 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eye stinging potential</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

